Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Lilly Announces Positive Results for Three Phase 3 Studies of Galcanezumab

lillyMay 15, 2017

Tag: Lilly , Galcanezumab

PharmaSources Customer Service